FDA Drug Application (022523) for PANCREAZE by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number022523
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage17,500USP/ UNITS;4,200USP/ UNITS;10,000USP/ UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePANCREAZE
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Active IngredientCount
List of drugs with Active Ingredient AMYLASE7
List of drugs with Active Ingredient LIPASE7
List of drugs with Active Ingredient PANCRELIPASE7
List of drugs with Active Ingredient PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)7
List of drugs with Active Ingredient PROTEASE7


Back to FDA Applications sponsored by JANSSEN PHARMS